MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-13-2025
Cytosorbents Corporation Cash and Cash Equivalents 2011-2026 | CTSO
Annual Cash and Cash Equivalents Cytosorbents Corporation
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3.28 M | 14.1 M | 22.1 M | 52.1 M | 71.4 M | 12.2 M | 22.4 M | 17.3 M | 5.25 M | 5.32 M | 3.61 M | 2.18 M | 1.73 M | 1.19 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 71.4 M | 1.19 M | 16.7 M |
Quarterly Cash and Cash Equivalents Cytosorbents Corporation
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 7.54 M | 10.2 M | 11.6 M | 3.28 M | 12.2 M | 14.9 M | 8.61 M | 14.1 M | 10 M | 14.8 M | 20.7 M | 22.1 M | 24.2 M | 31.9 M | 44.7 M | 52.1 M | 61 M | 65.6 M | 68.5 M | 71.4 M | 71.4 M | 71.4 M | 71.4 M | 12.2 M | 12.2 M | 12.2 M | 12.2 M | 22.4 M | 22.4 M | 22.4 M | 22.4 M | 17.3 M | 17.3 M | 17.3 M | 17.3 M | 5.25 M | 5.25 M | 5.25 M | 5.25 M | 5.32 M | 5.32 M | 5.32 M | 5.32 M | 3.61 M | 3.61 M | 3.61 M | 3.61 M | 2.18 M | 2.18 M | 2.18 M | 2.18 M | 1.73 M | 1.73 M | 1.73 M | 1.73 M | 1.19 M | 1.19 M | 1.19 M | 1.19 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 71.4 M | 1.19 M | 18.1 M |
Cash and Cash Equivalents of other stocks in the Medical devices industry
| Issuer | Cash and Cash Equivalents | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Aethlon Medical
AEMD
|
5.5 M | $ 2.23 | 0.52 % | $ 3.48 M |  USA |
 |
Acutus Medical
AFIB
|
19.2 M | - | -26.83 % | $ 2.62 M | USA |
 |
Allied Healthcare Products
AHPI
|
3.32 M | - | 3.58 % | $ 2.21 M | USA |
 |
AdaptHealth Corp.
AHCO
|
106 M | $ 10.41 | -0.41 % | $ 1.41 B | USA |
 |
ClearPoint Neuro
CLPT
|
45.9 M | $ 9.43 | -15.49 % | $ 267 M | USA |
 |
Alphatec Holdings
ATEC
|
161 M | $ 13.01 | -0.34 % | $ 1.95 B | USA |
 |
EDAP TMS S.A.
EDAP
|
24.7 M | $ 4.05 | 0.02 % | $ 151 M |  France |
 |
Avinger
AVGR
|
5.28 M | - | -20.74 % | $ 369 K | USA |
 |
Cognyte Software Ltd.
CGNT
|
78.6 M | $ 8.28 | -0.96 % | $ 594 M |  Israel |
 |
Establishment Labs Holdings
ESTA
|
75.6 M | $ 64.65 | -0.55 % | $ 1.91 B |  Costa-rica |
 |
Aziyo Biologics
AZYO
|
36.4 M | - | 1.37 % | $ 20.5 M | USA |
 |
Butterfly Network
BFLY
|
88.8 M | $ 4.16 | -2.58 % | $ 881 M | USA |
 |
BIOLASE
BIOL
|
6.57 M | - | -13.19 % | $ 166 K | USA |
 |
Conformis
CFMS
|
48.7 M | - | - | $ 16.4 M | USA |
 |
Boston Scientific Corporation
BSX
|
1.96 B | $ 70.72 | -0.67 % | $ 105 B | USA |
 |
Apollo Endosurgery
APEN
|
57 M | - | - | $ 475 M | USA |
 |
CONMED Corporation
CNMD
|
40.8 M | $ 37.25 | -0.24 % | $ 1.16 B | USA |
 |
Cutera
CUTR
|
144 M | - | -10.19 % | $ 1.99 M | USA |
 |
InMode Ltd.
INMD
|
68.9 M | $ 13.55 | -0.73 % | $ 876 M | Israel |
 |
Dynatronics Corporation
DYNT
|
326 K | - | 14.99 % | $ 929 K | USA |
 |
Axonics Modulation Technologies
AXNX
|
239 M | - | - | $ 3.31 B | USA |
 |
IRIDEX Corporation
IRIX
|
7.03 M | $ 1.33 | - | $ 21.5 M | USA |
 |
OrthoPediatrics Corp.
KIDS
|
19.6 M | $ 16.91 | -1.77 % | $ 397 M | USA |
 |
Neovasc
NVCN
|
51.5 M | - | - | $ 111 M |  Canada |
 |
FONAR Corporation
FONR
|
46.8 M | $ 18.43 | -0.11 % | $ 121 M | USA |
 |
GBS
GBS
|
1.02 M | - | -0.57 % | $ 7.12 M | USA |
 |
Abbott Laboratories
ABT
|
8.52 B | $ 109.71 | -0.9 % | $ 191 B | USA |
 |
Delcath Systems
DCTH
|
43.5 M | $ 9.59 | -1.54 % | $ 344 M | USA |
 |
Bio-Rad Laboratories
BIO
|
488 M | $ 268.09 | -0.52 % | $ 7.56 B | USA |
 |
Helius Medical Technologies
HSDT
|
5.18 M | $ 2.1 | -3.46 % | $ 1.28 M | USA |
 |
AxoGen
AXGN
|
35.5 M | $ 32.26 | -1.51 % | $ 1.49 B | USA |
 |
Align Technology
ALGN
|
1.04 B | $ 172.39 | -2.12 % | $ 12.9 B | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
246 M | $ 8.78 | -3.52 % | $ 676 M | USA |
 |
Bruker Corporation
BRKR
|
183 M | $ 33.42 | -0.95 % | $ 4.98 K | USA |
 |
BioSig Technologies
BSGM
|
142 K | - | 37.08 % | $ 85.7 M | USA |
 |
Apyx Medical Corporation
APYX
|
31.7 M | $ 3.9 | 4.28 % | $ 160 M | USA |
 |
Second Sight Medical Products
EYES
|
18.4 M | - | -0.97 % | $ 54.4 M | USA |
 |
Accuray Incorporated
ARAY
|
57.4 M | $ 0.37 | -4.45 % | $ 38 M | USA |
 |
IRadimed Corporation
IRMD
|
51.2 M | $ 103.06 | 0.25 % | $ 1.31 B | USA |